亚组 | 文献数量(篇) | 异质性检验 | 合并效应量 | ||
I2 | P | SMD (95%CI) | P | ||
ALT(AT) |
|
|
|
|
|
周期 |
|
|
|
|
|
≤16周 | 4 | 81% | 0.004 | −1.08 [−1.82, −0.34] | 0.37 |
>16周 | 3 | 0% | <0.00001 | −0.73 [−0.94, −0.51] |
|
频次 |
|
|
|
|
|
>3次/周 | 3 | 74% | 0.04 | −0.89 [−1.74, −0.04] | 0.8 |
≤3次/周 | 4 | 71% | <0.00001 | −0.97 [−1.38, −0.57] |
|
国家 |
|
|
|
|
|
沙特阿拉伯 | 1 | / | 0.01 | −0.95 [−1.70,−0.20] | 0.03* |
伊朗 | 1 | / | 0.001 | −1.79 [−2.87, −0.72] |
|
巴西 | 1 | / | 0.39 | −0.23 [−0.74, 0.29] |
|
中国 | 4 | 71% | <0.00001 | −0.97 [−1.38, −0.57] |
|
GGT (AT) |
|
|
|
|
|
周期 |
|
|
|
|
|
≤16周 | 1 | / | <0.00001 | −4.58 [−5.39,−3.76] | 0.23 |
>16周 | 4 | 98% | 0.02 | −2.95 [−5.45,−0.44] |
|
频次 |
|
|
|
|
|
≤3次/周 | 1 | / | 0.62 | 0.16 [−0.47, 0.78] | 0.02* |
>3次/周 | 4 | 99% | 0.02 | −4.18 [−7.75,−0.62] |
|
国家 |
|
|
|
|
|
巴西 | 1 | / | 0.62 | 0.16 [−0.47, 0.78] | 0.02* |
中国 | 4 | 99% | 0.02 | −4.18 [−7.75,−0.62] |
|
GGT (ART) |
|
|
|
|
|
周期 |
|
|
|
|
|
≤16周 | 2 | 78% | 0.70 | −0.24 [−1.46, 0.99] | < 0.00001* |
>16周 | 1 | / | <0.00001 | −7.90 [−9.27,−6.53] |
|
频次 |
|
|
|
|
|
≤3次/周 | 1 | / | 0.04 | −0.87 [−1.72,−0.03] | 0.49 |
>3次/周 | 2 | 99% | 0.37 | −3.74 [−11.85,4.37] |
|
国家 |
|
|
|
|
|
英国 | 2 | 78% | 0.70 | −0.24 [−1.46, 0.99] | < 0.00001* |
中国 | 1 | / | <0.00001 | −7.90 [−9.27,−6.53] |
|